col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Elsevier: The Lancet Microbe
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―28 Bamlanivimab as monotherapy in two immunocompromised patients with COVID-19 Grégory Destras, Souad Assaad, Antonin Bal, Maude Bouscambert-Duchamp, Virginie Avrillon, Bruno Simon, et al. (+5)
2 [GO] 2021―Jul―27 Genomic surveillance to combat COVID-19: challenges and opportunities Janet D Robishaw, Scott M Alter, Joshua J Solano, Richard D Shih, David L DeMets, Dennis G Maki, Charles H Hennekens
3 [GO] 2021―Jul―16 Comparative immunogenicity of mRNA and inactivated vaccines against COVID-19 Wey Wen Lim, Loretta Mak, Gabriel M Leung, Benjamin J Cowling, Malik Peiris
4 [GO] 2021―Jul―08 Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study William M Souza, Mariene R Amorim, Renata Sesti-Costa, Lais D Coimbra, Natalia S Brunetti, Daniel A Toledo-Teixeira, et al. (+50)
5 [GO] 2021―Jul―06 Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study Rishi K Gupta, Joshua Rosenheim, Lucy C Bell, Aneesh Chandran, Jose A Guerra-Assuncao, Gabriele Pollara, et al. (+128)
6 [GO] 2021―Jul―01 Rising antimicrobial resistance: an evolving epidemic in a pandemic Abi Manesh, George M Varghese
7 [GO] 2021―Jun―30 Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation study Suzanne Pickering, Rahul Batra, Blair Merrick, Luke B Snell, Gaia Nebbia, Sam Douthwaite, et al. (+15)
8 [GO] 2021―Jun―29 COVID-19 vaccination among Roma populations in Europe Ed Holt
9 [GO] 2021―Jun―29 WHO-Germany collaboration for pandemic intelligence research Vijay Shankar Balakrishnan
10 [GO] 2021―Jun―29 G7 leaders commit to greater pandemic preparedness (again) The Lancet Microbe
11 [GO] 2021―Jun―29 SARS-CoV-2 rapid diagnostic tests for emerging variants Meriem Bekliz, Kenneth Adea, Manel Essaidi-Laziosi, Jilian A Sacks, Camille Escadafal, Laurent Kaiser, Isabella Eckerle
12 [GO] 2021―Jun―28 Paucity and discordance of neutralising antibody responses to SARS-CoV-2 VOCs in vaccinated immunodeficient patients and health-care workers in the UK Angalee Nadesalingam, Diego Cantoni, David A Wells, Ernest T Aguinam, Matteo Ferrari, Peter Smith, et al. (+10)
13 [GO] 2021―Jun―23 Invasive mould disease in fatal COVID-19: a systematic review of autopsies Brittany E Kula, Cornelius J Clancy, M Hong Nguyen, Ilan S Schwartz
14 [GO] 2021―Jun―18 Beyond vaccine hesitancy: time for Africa to expand vaccine manufacturing capacity amidst growing COVID-19 vaccine nationalism Akaninyene Otu, Egbe Osifo-Dawodu, Phionah Atuhebwe, Emmanuel Agogo, Bassey Ebenso
15 [GO] 2021―Jun―08 SARS-CoV-2 emerging variants in Africa: view from Gabon Samira Zoa-Assoumou, Bénédicte Ndeboko, Gédéon Prince Manouana, Rotimi Myrabelle Avome Houechenou, Rodrigue Bikangui, Amandine Mveang-Nzoghe, et al. (+9)
16 [GO] 2021―Jun―02 India grapples with second wave of COVID-19 Udani Samarasekera
17 [GO] 2021―Jun―02 Combining immunomodulators and antivirals for COVID-19 Luke Y C Chen, Tien T T Quach
18 [GO] 2021―Jun―02 Combining immunomodulators and antivirals for COVID-19 - Authors' reply Raquel Almansa, Ana P Tedim, Amanda de la Fuente, Jose María Eiros, David J Kelvin, Antoni Torres, Jesus F Bermejo-Martin
19 [GO] 2021―Jun―02 Convalescent plasma transfusion for pregnant patients with COVID-19 Antonio Mastroianni, Sonia Greco, Maria Vittoria Mauro, Luciana Chidichimo, Valeria Vangeli
20 [GO] 2021―Jun―02 Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study Clark D Russell, Cameron J Fairfield, Thomas M Drake, Lance Turtle, R Andrew Seaton, Dan G Wootton, et al. (+366)
21 [GO] 2021―May―19 A novel strategy for SARS-CoV-2 mass screening with quantitative antigen testing of saliva: a diagnostic accuracy study Isao Yokota, Peter Y Shane, Kazufumi Okada, Yoko Unoki, Yichi Yang, Sumio Iwasaki, et al. (+3)
22 [GO] 2021―May―14 COVID-19 vaccines: effectiveness and number needed to treat - Authors' reply Piero Olliaro, Els Torreele, Michel Vaillant
23 [GO] 2021―May―14 COVID-19 vaccines: effectiveness and number needed to treat Luis C L Correia, Denise Matias
24 [GO] 2021―May―12 Rapid tests for quantification of infectiousness are urgently required in patients with COVID-19 Daniel Pan, Shirley Sze, Shalin Abraham, Caroline M Williams, Julian W Tang, Mike R Barer, Manish Pareek
25 [GO] 2021―May―04 No end in sight for the Brazilian COVID-19 crisis Talha Burki
26 [GO] 2021―Apr―21 Targeting hyperinflammation in infection: can we harness the COVID-19 therapeutics momentum to end the dengue drugs drought? Angela McBride, Puja Mehta, Laura Rivino, Athimalaipet V Ramanan, Sophie Yacoub
27 [GO] 2021―Apr―21 COVID-19 vaccine efficacy and effectiveness-the elephant (not) in the room Piero Olliaro, Els Torreele, Michel Vaillant
28 [GO] 2021―Apr―16 Mounting evidence of impaired viral control in severe COVID-19 Jesus F Bermejo-Martin, Raquel Almansa, Ana P Tedim, Amanda de la Fuente, Jose María Eiros, Antoni Torres, David J Kelvin
29 [GO] 2021―Apr―15 Serum sample neutralisation of BBIBP-CorV and ZF2001 vaccines to SARS-CoV-2 501Y.V2 Baoying Huang, Lianpan Dai, Hui Wang, Zhongyu Hu, Xiaoming Yang, Wenjie Tan, George F Gao
30 [GO] 2021―Apr―07 Comparison of seven commercial SARS-CoV-2 rapid point-of-care antigen tests: a single-centre laboratory evaluation study Victor M Corman, Verena Claudia Haage, Tobias Bleicker, Marie Luisa Schmidt, Barbara Mühlemann, Marta Zuchowski, et al. (+7)
31 [GO] 2021―Apr―07 SARS-CoV-2 spike E484K mutation reduces antibody neutralisation Sonia Jangra, Chengjin Ye, Raveen Rathnasinghe, Daniel Stadlbauer, Florian Krammer, Viviana Simon, et al. (+24)
32 [GO] 2021―Apr―01 A method for detection of SARS-CoV-2 RNA in healthy human stool: a validation study Michael P Coryell, Mikhail Iakiviak, Nicole Pereira, Pallavi P Murugkar, Jason Rippe, David B Williams, et al. (+10)
33 [GO] 2021―Mar―31 Potential benefit of convalescent plasma transfusions in immunocompromised patients with COVID-19 Roman N Rodionov, Anne Biener, Peter Spieth, Martin Achleitner, Kristina Hölig, Martin Aringer, et al. (+6)
34 [GO] 2021―Mar―31 Endogenous IFNβ expression predicts outcome in critical patients with COVID-19 Soraya Maria Menezes, Marcos Braz, Veronica Llorens-Rico, Joost Wauters, Johan Van Weyenbergh
35 [GO] 2021―Mar―31 Challenges of SARS-CoV-2 genomic surveillance in Africa Paul Adepoju
36 [GO] 2021―Mar―23 Convalescent plasma from people vaccinated after COVID-19 infection Kamal Abu Jabal, Karine Beiruti Wiegler, Michael Edelstein
37 [GO] 2021―Mar―23 Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study Wan Ni Chia, Feng Zhu, Sean Wei Xiang Ong, Barnaby Edward Young, Siew-Wai Fong, Nina Le Bert, et al. (+16)
38 [GO] 2021―Mar―21 Learning from COVID-19 to reimagine tuberculosis diagnosis Morten Ruhwald, Sergio Carmona, Madhukar Pai
39 [GO] 2021―Mar―14 Perfect as the enemy of good: tracing transmissions with low-sensitivity tests to mitigate SARS-CoV-2 outbreaks Lee Kennedy-Shaffer, Michael Baym, William P Hanage
40 [GO] 2021―Mar―12 Surveillance of SARS-CoV-2 in Zimbabwe shows dominance of variants of concern Tapfumanei Mashe, Faustinos Tatenda Takawira, Hlanai Gumbo, Agnes Juru, Charles Nyagupe, Kenneth K Maeka, et al. (+7)
41 [GO] 2021―Mar―07 Interferon antagonism by SARS-CoV-2: a functional study using reverse genetics Simon Schroeder, Fabian Pott, Daniela Niemeyer, Talitha Veith, Anja Richter, Doreen Muth, et al. (+3)
42 [GO] 2021―Mar―03 Revisiting the initial COVID-19 pandemic projections Adam T Biggs, Lanny F Littlejohn
43 [GO] 2021―Feb―24 SARS-CoV-2: eye protection might be the missing key Minas Theodore Coroneo, Peter John Collignon
44 [GO] 2021―Feb―24 COVID-19 drug practices risk antimicrobial resistance evolution Ebrahim Afshinnekoo, Chandrima Bhattacharya, Ana Burguete-García, Eduardo Castro-Nallar, Youping Deng, Christelle Desnues, et al. (+15)
45 [GO] 2021―Feb―21 The journey towards safely restarting faecal microbiota transplantation services in the UK during the COVID-19 era Mohammed Nabil Quraishi, Sahida Shabir, Susan E Manzoor, Christopher A Green, Naveen Sharma, Andrew D Beggs, Tariq H Iqbal
46 [GO] 2021―Feb―10 SARS-CoV-2 vaccines: fast track versus efficacy Dana Alkandari, Jenny A Herbert, Moustafa A Alkhalaf, Carol Yates, Stavros Panagiotou
47 [GO] 2021―Feb―06 COVID-19 cytokine storm syndrome: a threshold concept Luke Y C Chen, Tien T T Quach
48 [GO] 2021―Feb―06 Neutrophils as a pallbearer for SARS-CoV-2 disease burden - Authors’ reply René Lutter, Bernadette Schurink, Eva Roos, Lihui Guo, Paul van der Valk, Marianna Bugiani
49 [GO] 2021―Feb―05 Africa prepares for COVID-19 vaccines Paul Adepoju
50 [GO] 2021―Feb―05 Neutrophils as a pallbearer for SARS-CoV-2 disease burden David DW Twa, Christine D Lukac, Kevin Kuchinski, Aidan Nikiforuk, Inna Sekirov
51 [GO] 2021―Jan―27 Monitoring of human coronaviruses in Belgian primary care and hospitals, 2015-20: a surveillance study Natalie Fischer, Nicolas Dauby, Nathalie Bossuyt, Marijke Reynders, Michèle Gérard, Patrick Lacor, et al. (+12)
52 [GO] 2021―Jan―19 Insight into the practical performance of RT-PCR testing for SARS-CoV-2 using serological data: a cohort study Zhen Zhang, Qifang Bi, Shisong Fang, Lan Wei, Xin Wang, Jianfan He, et al. (+9)
53 [GO] 2020―Dec―21 Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning study Jason Rosado, Stéphane Pelleau, Charlotte Cockram, Sarah Hélène Merkling, Narimane Nekkab, Caroline Demeret, et al. (+13)
54 [GO] 2020―Dec―18 COVID-19 vaccines: the pandemic will not end overnight The Lancet Microbe
55 [GO] 2020―Dec―07 Mass testing for COVID-19 Talha Burki
56 [GO] 2020―Dec―07 How a microbe becomes a pandemic: a new story of the Black Death Monica H Green
57 [GO] 2020―Nov―20 SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis Muge Cevik, Matthew Tate, Ollie Lloyd, Alberto Enrico Maraolo, Jenna Schafers, Antonia Ho
58 [GO] 2020―Nov―05 Immunogenomic phases of COVID-19 and appropriate clinical management Ibrahim C Haznedaroglu
59 [GO] 2020―Nov―05 Innovative point-of-care molecular diagnostic test for COVID-19 in India Nivedita Gupta, Salaj Rana, Harpreet Singh
60 [GO] 2020―Nov―05 Changes in clinical laboratory operations and biosafety measures to mitigate biohazard risks during the COVID-19 pandemic Kay Weng Choy
61 [GO] 2020―Nov―05 COVID-19 response in central Asia Vijay Shankar Balakrishnan
62 [GO] 2020―Nov―05 Using genomics to improve preparedness and response of future epidemics or pandemics in Africa Chrispin Chaguza, Martin M Nyaga, Jason M Mwenda, Mathew D Esona, Khuzwayo C Jere
63 [GO] 2020―Nov―03 Co-infections: testing macrolides for added benefit in patients with COVID-19 Katharina Anna Sterenczak, Israel Barrantes, Thomas Stahnke, Oliver Stachs, Georg Fuellen, Nasrullah Undre
64 [GO] 2020―Oct―30 Innovation in wastewater near-source tracking for rapid identification of COVID-19 in schools Francis Hassard, Lian Lundy, Andrew C Singer, Jasmine Grimsley, Mariachiara Di Cesare
65 [GO] 2020―Oct―24 Dexamethasone and remdesivir: finding method in the COVID-19 madness Pauline Vetter, Laurent Kaiser, Alexandra Calmy, Thomas Agoritsas, Angela Huttner
66 [GO] 2020―Oct―07 NTDs in the time of COVID-19 Paul Adepoju
67 [GO] 2020―Oct―07 Cerebrospinal fluid findings in COVID-19 indicate autoimmunity Guglielmo Lucchese
68 [GO] 2020―Oct―07 COVID-19: we will not be returning to the old normal The Lancet Microbe
69 [GO] 2020―Sep―25 Humoral response and PCR positivity in patients with COVID-19 in the New York City region, USA: an observational study Ania Wajnberg, Mayce Mansour, Emily Leven, Nicole M Bouvier, Gopi Patel, Adolfo Firpo-Betancourt, et al. (+13)
70 [GO] 2020―Sep―25 Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study Bernadette Schurink, Eva Roos, Teodora Radonic, Ellis Barbe, Catherine S C Bouman, Hans H de Boer, et al. (+24)
71 [GO] 2020―Sep―17 Assessing a novel, lab-free, point-of-care test for SARS-CoV-2 (CovidNudge): a diagnostic accuracy study Malick M Gibani, Christofer Toumazou, Mohammadreza Sohbati, Rashmita Sahoo, Maria Karvela, Tsz-Kin Hon, et al. (+27)
72 [GO] 2020―Sep―07 COVID-19 and fungal infection: the need for a strategic approach P Lewis White, Rishi Dhillon, Harriet Hughes, Matthew P Wise, Matthijs Backx
73 [GO] 2020―Sep―07 A locally sustainable approach to COVID-19 testing in Africa Elijah Songok
74 [GO] 2020―Sep―07 In preparation for a COVID-19-influenza double epidemic Vijay Shankar Balakrishnan
75 [GO] 2020―Aug―20 Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study Brian Hanley, Kikkeri N Naresh, Candice Roufosse, Andrew G Nicholson, Justin Weir, Graham S Cooke, et al. (+12)
76 [GO] 2020―Aug―18 Accelerating genomics-based surveillance for COVID-19 response in Africa Sofonias K Tessema, Seth C Inzaule, Alan Christoffels, Yenew Kebede, Tulio de Oliveira, Ahmed E Ogwell Ouma, et al. (+2)
77 [GO] 2020―Aug―06 Surveillance for COVID-19-associated pulmonary aspergillosis Li-An K Brown, Jayne Ellis, Rebecca Gorton, Surjo De, Neil Stone
78 [GO] 2020―Aug―06 Arboviruses and COVID-19: the need for a holistic view The Lancet Microbe
79 [GO] 2020―Aug―06 Cross-reactivity towards SARS-CoV-2: the potential role of low-pathogenic human coronaviruses Zhongren Ma, Pengfei Li, Yuepeng Ji, Aqsa Ikram, Qiuwei Pan
80 [GO] 2020―Aug―06 Stability of SARS-CoV-2 in different environmental conditions Reza Dehbandi, Mohammad Ali Zazouli
81 [GO] 2020―Aug―06 Stability of SARS-CoV-2 in different environmental conditions - Authors' reply Alex W H Chin, Leo L M Poon
82 [GO] 2020―Aug―06 Seroprevalence of SARS-CoV-2 in Hong Kong returnees William P Hanage, Victor I Vincent, Nicola M Low
83 [GO] 2020―Aug―06 Seroprevalence of SARS-CoV-2 in Hong Kong returnees - Authors' reply Kelvin Kai-Wang To, Kwok-Yung Yuen
84 [GO] 2020―Aug―06 Anosmia and hyposmia in health-care workers with undiagnosed SARS-CoV-2 infection Matt Lechner, Nicholas Counsell, Jacklyn Liu, Nicholas Eynon-Lewis, Santdeep Paun, Valerie J Lund, et al. (+2)
85 [GO] 2020―Jul―28 The challenges of informative wastewater sampling for SARS-CoV-2 must be met: lessons from polio eradication Kathleen M O'Reilly, David J Allen, Paul Fine, Humayun Asghar
86 [GO] 2020―Jul―16 Towards pandemic preparedness beyond COVID-19 Mahmoud M Naguib, Patrik Ellström, Josef D Järhult, Åke Lundkvist, Björn Olsen
87 [GO] 2020―Jul―07 SARS-CoV-2 in fruit bats, ferrets, pigs, and chickens: an experimental transmission study Kore Schlottau, Melanie Rissmann, Annika Graaf, Jacob Schön, Julia Sehl, Claudia Wylezich, et al. (+8)
88 [GO] 2020―Jul―03 The role of oral bacteria in COVID-19 Jay Patel, Victoria Sampson
89 [GO] 2020―Jul―03 COVID-19 and fungal superinfection Katie L Heard, Stephen Hughes, Nabeela Mughal, Luke S P Moore
90 [GO] 2020―Jul―03 COVID-19 testing in Africa: lessons learnt Pascale Ondoa, Yenew Kebede, Marguerite Massinga Loembe, Jinal N Bhiman, Sofonias Kifle Tessema, Abdourahmane Sow, et al. (+2)
91 [GO] 2020―Jul―03 Development of potential COVID-19 vaccines continues to accelerate Tony Kirby
92 [GO] 2020―Jul―03 COVID-19-associated pulmonary aspergillosis: adding insult to injury Giuseppe Bruno, Claudia Fabrizio, Giovanni Battista Buccoliero
93 [GO] 2020―Jul―03 COVID-19: a multifaceted threat to refugee camps Talha Burki
94 [GO] 2020―Jul―02 Anthroponotic risk of SARS-CoV-2, precautionary mitigation, and outbreak management Sarah J L Edwards, Joanne M Santini
95 [GO] 2020―Jun―18 Host range of SARS-CoV-2 and implications for public health Joanne M Santini, Sarah J L Edwards
96 [GO] 2020―Jun―11 Systematic SARS-CoV-2 screening in cerebrospinal fluid during the COVID-19 pandemic Grégory Destras, Antonin Bal, Vanessa Escuret, Florence Morfin, Bruno Lina, Laurence Josset
97 [GO] 2020―Jun―08 Low rate of bacterial co-infection in patients with COVID-19 Hugh Adler, Robert Ball, Michael Fisher, Kalani Mortimer, Madhur S Vardhan
98 [GO] 2020―Jun―08 COVID-19 and measles: double trouble for Burundi Sanjeet Bagcchi
99 [GO] 2020―Jun―08 COVID-19 diagnostics-not at the expense of other diseases Priya Venkatesan
100 [GO] 2020―Jun―08 Monitoring investments in coronavirus research and development Rebecca J Brown, Michael G Head
101 [GO] 2020―Jun―08 Optimising SARS-CoV-2 pooled testing for low-resource settings Farhan Majid, Saad B Omer, Asim Ijaz Khwaja
102 [GO] 2020―Jun―08 Stability and neutralising capacity of SARS-CoV-2-specific antibodies in convalescent plasma Torsten Tonn, Victor M Corman, Matthias Johnsen, Anja Richter, Roman N Rodionov, Christian Drosten, Stefan R Bornstein
103 [GO] 2020―Jun―03 Seroprevalence of SARS-CoV-2 in Hong Kong and in residents evacuated from Hubei province, China: a multicohort study Kelvin Kai-Wang To, Vincent Chi-Chung Cheng, Jian-Piao Cai, Kwok-Hung Chan, Lin-Lei Chen, Lok-Hin Wong, et al. (+16)
104 [GO] 2020―Jun―03 Population serology for SARS-CoV-2 is essential to regional and global preparedness Huaiyu Tian, Ottar N Bjornstad
105 [GO] 2020―Jun―02 An integrated national scale SARS-CoV-2 genomic surveillance network
106 [GO] 2020―May―11 Increasing accessibility in COVID-19 clinical trials Vijay Shankar Balakrishnan
107 [GO] 2020―May―11 Africa's struggle with inadequate COVID-19 testing Paul Adepoju
108 [GO] 2020―May―11 Solar ultraviolet radiation sensitivity of SARS-CoV-2 Ayse Seyer, Tamer Sanlidag
109 [GO] 2020―May―10 Diagnosing COVID-19-associated pulmonary aspergillosis Paul E Verweij, Jean-Pierre Gangneux, Matteo Bassetti, Roger J M Brüggemann, Oliver A Cornely, Philipp Koehler, et al. (+4)
110 [GO] 2020―Apr―24 Co-infections: potentially lethal and unexplored in COVID-19 Michael J Cox, Nicholas Loman, Debby Bogaert, Justin O'Grady
111 [GO] 2020―Apr―21 Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study Hin Chu, Jasper Fuk-Woo Chan, Terrence Tsz-Tai Yuen, Huiping Shuai, Shuofeng Yuan, Yixin Wang, et al. (+22)
112 [GO] 2020―Apr―21 SARS-CoV-2 cellular tropism Valeria Cagno
113 [GO] 2020―Apr―02 Stability of SARS-CoV-2 in different environmental conditions Alex W H Chin, Julie T S Chu, Mahen R A Perera, Kenrie P Y Hui, Hui-Ling Yen, Michael C W Chan, et al. (+2)
114 [GO] 2020―Apr―01 From PREDICT to prevention, one pandemic later Colin J Carlson


Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.006 sec